Prophylactic thiamine to reduce neurologic AEs in patients with MF treated with fedratinib VJHemOnc – Video Journal of Hematology & HemOnc 0:51 5 months ago 48 Далее Скачать
Defining suboptimal response to ruxolitinib and the strategy for switching treatments VJHemOnc – Video Journal of Hematology & HemOnc 0:53 3 months ago 56 Далее Скачать
Drugs under investigation for patients with MF who have failed treatment with JAK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 1:15 2 years ago 61 Далее Скачать
Results of the RUXOPEG trial: combining ruxolitinib and interferon in patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:30 3 months ago 138 Далее Скачать
Ruxolitinib combinations in patients with myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 2:14 1 year ago 151 Далее Скачать
The impact of early ruxolitinib treatment on OS in the COMFORT-I and COMFORT-II studies VJHemOnc – Video Journal of Hematology & HemOnc 1:20 1 year ago 70 Далее Скачать
Momelotinib vs. ruxolitinib in myelofibrosis patients with thrombocytopenia VJHemOnc – Video Journal of Hematology & HemOnc 1:42 3 years ago 440 Далее Скачать
New therapies for MPNs VJHemOnc – Video Journal of Hematology & HemOnc 2:05 4 years ago 40 Далее Скачать
Imetelstat in high-risk triple-negative myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 1:24 4 years ago 838 Далее Скачать
The correlation between JAK2v617f molecular response and EFS in patients with early PV VJHemOnc – Video Journal of Hematology & HemOnc 1:21 5 months ago 255 Далее Скачать
Molecular profiling and risk classification of patients with MPNs and splanchnic vein thromboses VJHemOnc – Video Journal of Hematology & HemOnc 2:18 4 years ago 65 Далее Скачать
Approved & emerging JAK inhibitors for patients with high-risk MF who are transplant-ineligible VJHemOnc – Video Journal of Hematology & HemOnc 2:09 1 year ago 129 Далее Скачать
Agents of interest being explored in essential thrombocythemia and polycythemia vera VJHemOnc – Video Journal of Hematology & HemOnc 1:26 2 years ago 252 Далее Скачать
What's new in myeloproliferative neoplasms? VJHemOnc – Video Journal of Hematology & HemOnc 1:45 8 years ago 358 Далее Скачать
Key highlights in MPNs at ASH 2023: novel agents & combinations, ongoing clinical trials, and more VJHemOnc – Video Journal of Hematology & HemOnc 16:35 11 months ago 1 214 Далее Скачать
What can be learnt about using interferon in patients with myelofibrosis? VJHemOnc – Video Journal of Hematology & HemOnc 2:28 6 years ago 1 417 Далее Скачать
The role of navtemadlin in the MPN treatment landscape VJHemOnc – Video Journal of Hematology & HemOnc 0:56 2 years ago 132 Далее Скачать
Design and results of pacritinib for myelofibrosis trial (PERSIST-1) VJHemOnc – Video Journal of Hematology & HemOnc 1:45 9 years ago 71 Далее Скачать
